Compare NGEN & FC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NGEN | FC |
|---|---|---|
| Founded | 2017 | 1983 |
| Country | Canada | United States |
| Employees | 9 | N/A |
| Industry | | Other Consumer Services |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.5M | 231.6M |
| IPO Year | N/A | 1994 |
| Metric | NGEN | FC |
|---|---|---|
| Price | $1.61 | $21.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $18.00 | ★ $26.00 |
| AVG Volume (30 Days) | ★ 739.3K | 107.0K |
| Earning Date | 04-02-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $267,067,000.00 |
| Revenue This Year | N/A | $3.15 |
| Revenue Next Year | N/A | $4.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.59 | $11.16 |
| 52 Week High | $5.93 | $26.81 |
| Indicator | NGEN | FC |
|---|---|---|
| Relative Strength Index (RSI) | 32.53 | 52.04 |
| Support Level | N/A | $20.36 |
| Resistance Level | $2.22 | $24.13 |
| Average True Range (ATR) | 0.11 | 0.97 |
| MACD | 0.01 | 0.20 |
| Stochastic Oscillator | 2.32 | 89.19 |
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.
Franklin Covey Co is a company focused on organizational performance improvement. It operates in the business segments of North America, International Direct Offices, International Licensees, Education Division. The company derives revenue from providing training and consulting services and through the sale of books, audio media, and other related products. It has a business presence in Australia, New Zealand, China, Japan, the United Kingdom, Ireland, and Other countries.